Lakefront Biotherapeutics | GLPG - Stock

Stock Price
23.18
Daily Change
-0.22 -0.94%
Monthly
-6.76%
Yearly
-6.00%
Q2 Forecast
22.89

Lakefront Biotherapeutics reported EUR17.69M in Stock for its fiscal quarter ending in March of 2026.





Stock Change Date
argenx SE USD 473.53M 132.91M Dec/2025
AstraZeneca USD 6.57B 13M Mar/2026
Biogen USD 1.95B 219.1M Mar/2026
Genmab DKK 13M 1000K Jun/2025
Gilead Sciences USD 1.91B 140M Mar/2026
GlaxoSmithKline GBP 6.16B 233M Mar/2026
GRIFOLS EUR 3.35B 213.23M Jun/2025
Hikma Pharmaceutical USD 1.08B 96M Jun/2025
Incyte USD 115.62M 14.56M Mar/2026
Merck EUR 4.56B 52M Dec/2025
Neurocrine Biosciences USD 64.5M 4.5M Mar/2026
Novartis USD 6.29B 17M Mar/2026
Roche Holding CHF 7.6B 9M Jun/2025
Sanofi EUR 22.69B 1.81B Dec/2025
UCB EUR 1.31B 173M Dec/2024
Vertex Pharmaceuticals USD 1.77B 79.9M Mar/2026